Bumper Offer - Urjas oil Just @ Rs. 1 X
Nitro 2.6 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Urinary Tract Infection. Nitro 2.6 Mg Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Nitro 2.6 Mg Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Nitro 2.6 Mg Tablet can also lead to other problems, which have been listed below. Usually, these side effects of Nitro 2.6 Mg Tablet go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Nitro 2.6 Mg Tablet's effect during pregnancy is Safe and Moderate while nursing. It is important to know if Nitro 2.6 Mg Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Nitro 2.6 Mg Tablet related warnings section.
Nitro 2.6 Mg Tablet is contraindicated in people with pre-existing medical conditions like Kidney Disease, Anemia, Liver Disease as it can result in adverse effects. Some other conditions that can be affected by Nitro 2.6 Mg Tablet are listed in the contraindications section below.
Besides this, Nitro 2.6 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Nitro 2.6 Mg Tablet is not safe while driving, and is not addiction.
Nitro 2.6 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Nitro 2.6 Mg Tablet is used -
Severe
Moderate
Mild
Is the use of Nitro 2.6 Mg Tablet safe for pregnant women?
There are no side effects of Nitro in pregnant women.
Is the use of Nitro 2.6 Mg Tablet safe during breastfeeding?
Nitro may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Nitro, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Nitro.
What is the effect of Nitro 2.6 Mg Tablet on the Kidneys?
Nitro rarely affects the kidneys.
What is the effect of Nitro 2.6 Mg Tablet on the Liver?
Nitro is rarely harmful for the liver.
What is the effect of Nitro 2.6 Mg Tablet on the Heart?
Side effects of Nitro rarely affect the heart.
Nitro 2.6 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Nitro 2.6 Mg Tablet unless your doctor advises you to do so -
Is this Nitro 2.6 Mg Tablet habit forming or addictive?
Nitro 2.6 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nitro 2.6 Mg Tablet, you should not drive or work on any heavy machine, as Nitro 2.6 Mg Tablet can make you drowsy.
Is it safe?
Yes, Nitro 2.6 Mg Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Nitro 2.6 Mg Tablet for mental disorders.
Interaction between Food and Nitro 2.6 Mg Tablet
You can take Nitro 2.6 Mg Tablet with food.
Interaction between Alcohol and Nitro 2.6 Mg Tablet
Drinking alcohol while on Nitro 2.6 Mg Tablet does not produce side effects. However, it is in your best interest to be careful.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915